Anaxone SB 1000mg/500mg Injection
Marketer
Anabolic Remedies Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Anaxone SB 1000mg/500mg Injection
Anaxone SB, a 1000mg/500mg injectable dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and spread. Administer this medication solely under professional medical guidance; strictly adhere to the prescribed dosage schedule. Complete the entire treatment course, regardless of symptom improvement, as premature cessation might compromise its effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; promptly consult your physician should these worsen. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor of all current medications, particularly if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid operation of vehicles if experiencing somnolence or vertigo. Prioritize rest, nutrition, and hydration for optimal recovery. Your doctor may order lab tests to monitor treatment response.
Primary Ingredients of Anaxone SB 1000mg/500mg Injection
No information provided. Please provide the text you wish to be rewritten.
Uses of Anaxone SB 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Anaxone SB 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Anaxone SB 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Anaxone SB 1000mg/500mg Injection:
The medication will be administered by your physician or their qualified nurse; self-medication is strictly prohibited.
How Anaxone SB 1000mg/500mg Injection works:
The injectable formulation Anaxone SB (1000mg/500mg) unites Ceftriaxone, a bacterial growth inhibitor, and Sulbactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their survival. Sulbactam complements this by overcoming bacterial resistance mechanisms, thereby boosting Ceftriaxone's efficacy.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Anaxone SB 1000mg/500mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Anaxone SB 1000mg/500mg Injection is typically regarded as safe for use during pregnancy. Preclinical trials in animals have revealed minimal or no negative impacts on fetal development; nevertheless, clinical data in humans are scarce.
Breast feedingCAUTION
The administration of Anaxone SB 1000mg/500mg Injection necessitates prudence while breastfeeding. Mothers should discontinue breastfeeding for the duration of their treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Anaxone SB 1000mg/500mg Injection could reduce awareness, impair vision, and induce drowsiness or vertigo. Driving is prohibited should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Anaxone SB 1000mg/500mg Injection to individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCAUTION
Anaxone SB 1000mg/500mg Injection requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Medical advice is recommended. Dosage alteration for Anaxone SB 1000mg/500mg Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Anaxone SB 1000mg/500mg Injection :
Should you forget a scheduled Anaxone SB 1000mg/500mg Injection, seek medical advice.
Facts to Know About Anaxone SB 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently